Literature DB >> 16680782

Developmental regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid receptor subunit expression in forebrain and relationship to regional susceptibility to hypoxic/ischemic injury. I. Rodent cerebral white matter and cortex.

Delia M Talos1, Rachel E Fishman, Hyunkyung Park, Rebecca D Folkerth, Pamela L Follett, Joseph J Volpe, Frances E Jensen.   

Abstract

This is the first part of a two-part study to investigate the cellular distribution and temporal regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid receptor (AMPAR) subunits in the developing white matter and cortex in rat (part I) and human (part II). Western blot and immunocytochemistry were used to evaluate the differential expression of AMPAR subunits on glial and neuronal subtypes during the first 3 postnatal weeks in the Long Evans and Sprague Dawley rat strains. In Long Evans rats during the first postnatal week, GluR2-lacking AMPARs were expressed predominantly on white matter cells, including radial glia, premyelinating oligodendrocytes, and subplate neurons, whereas, during the second postnatal week, these AMPARs were highly expressed on cortical neurons, coincident with decreased expression on white matter cells. Immunocytochemical analysis revealed that cell-specific developmental changes in AMPAR expression occurred 2-3 days earlier by chronological age in Sprague Dawley rats compared with Long Evans rats, despite overall similar temporal sequencing. In both white and gray matter, the periods of high GluR2 deficiency correspond to those of regional susceptibility to hypoxic/ischemic injury in each of the two rat strains, supporting prior studies suggesting a critical role for Ca2+-permeable AMPARs in excitotoxic cellular injury and epileptogenesis. The developmental regulation of these receptor subunits strongly suggests that Ca2+ influx through GluR2-lacking AMPARs may play an important role in neuronal and glial development and injury in the immature brain. Moreover, as demonstrated in part II, there are striking similarities between rat and human in the regional and temporal maturational regulation of neuronal and glial AMPAR expression. Copyright 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16680782      PMCID: PMC4313670          DOI: 10.1002/cne.20972

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  103 in total

1.  Type-2 astrocyte-like cells are more resistant than oligodendrocyte-like cells against non-N-methyl-D-aspartate glutamate receptor-mediated excitotoxicity.

Authors:  Yoko Yamaya; Akira Yoshioka; Shinji Saiki; Natsuko Yuki; Genjiro Hirose; David Pleasure
Journal:  J Neurosci Res       Date:  2002-11-15       Impact factor: 4.164

2.  Development of the human motor-related thalamic nuclei during the first half of gestation, with special emphasis on GABAergic circuits.

Authors:  Kristy Kultas-Ilinsky; Catherine Fallet; Catherine Verney
Journal:  J Comp Neurol       Date:  2004-08-23       Impact factor: 3.215

Review 3.  The TiPS/TINS lecture: the molecular biology of mammalian glutamate receptor channels.

Authors:  P H Seeburg
Journal:  Trends Pharmacol Sci       Date:  1993-08       Impact factor: 14.819

4.  Role of GluR2 expression in AMPA-induced toxicity in cultured murine cerebral cortical neurons.

Authors:  J B Jensen; T M Lund; D B Timmermann; A Schousboe; D S Pickering
Journal:  J Neurosci Res       Date:  2001-08-01       Impact factor: 4.164

5.  Calbindin-D28k immunoreactivity and selective vulnerability to ischemia in the dentate gyrus of the developing rat.

Authors:  J H Goodman; C G Wasterlain; W F Massarweh; E Dean; A L Sollas; R S Sloviter
Journal:  Brain Res       Date:  1993-03-26       Impact factor: 3.252

6.  Quantitative analysis of perinatal rodent oligodendrocyte lineage progression and its correlation with human.

Authors:  Andrew Craig; Ning Ling Luo; Douglas J Beardsley; Nasiema Wingate-Pearse; David W Walker; A Roger Hohimer; Stephen A Back
Journal:  Exp Neurol       Date:  2003-06       Impact factor: 5.330

7.  Glutamate receptor subunit 3 (GluR3) immunoreactivity delineates a subpopulation of parvalbumin-containing interneurons in the rat hippocampus.

Authors:  Diana E Moga; William G M Janssen; Prabhakar Vissavajjhala; Sharon M Czelusniak; Thomas M Moran; Patrick R Hof; John H Morrison
Journal:  J Comp Neurol       Date:  2003-07-14       Impact factor: 3.215

8.  The putative essential nutrient pyrroloquinoline quinone is neuroprotective in a rodent model of hypoxic/ischemic brain injury.

Authors:  F E Jensen; G J Gardner; A P Williams; P M Gallop; E Aizenman; P A Rosenberg
Journal:  Neuroscience       Date:  1994-09       Impact factor: 3.590

9.  A rat model for hypoxic-ischemic brain damage in very premature infants.

Authors:  R A Sheldon; J Chuai; D M Ferriero
Journal:  Biol Neonate       Date:  1996

10.  A role for glutamate and its receptors in the regulation of oligodendrocyte development in cerebellar tissue slices.

Authors:  X Yuan; A M Eisen; C J McBain; V Gallo
Journal:  Development       Date:  1998-08       Impact factor: 6.868

View more
  69 in total

Review 1.  Pathophysiology of glia in perinatal white matter injury.

Authors:  Stephen A Back; Paul A Rosenberg
Journal:  Glia       Date:  2014-03-31       Impact factor: 7.452

2.  Attenuating Ischemic Disruption of K+ Homeostasis in the Cortex of Hypoxic-Ischemic Neonatal Rats: DOR Activation vs. Acupuncture Treatment.

Authors:  Dongman Chao; Qinyu Wang; Gianfranco Balboni; Guanghong Ding; Ying Xia
Journal:  Mol Neurobiol       Date:  2015-12-19       Impact factor: 5.590

3.  Regulation of seizure-induced MeCP2 Ser421 phosphorylation in the developing brain.

Authors:  Evan C Rosenberg; Jocelyn J Lippman-Bell; Marcus Handy; Samantha S Soldan; Sanjay Rakhade; Cristina Hilario-Gomez; Kaitlyn Folweiler; Leah Jacobs; Frances E Jensen
Journal:  Neurobiol Dis       Date:  2018-05-05       Impact factor: 5.996

4.  Neural reconnection in the transected spinal cord of the freshwater turtle Trachemys dorbignyi.

Authors:  María Inés Rehermann; Nicolás Marichal; Raúl E Russo; Omar Trujillo-Cenóz
Journal:  J Comp Neurol       Date:  2009-07-10       Impact factor: 3.215

5.  Developmental expression of N-methyl-D-aspartate (NMDA) receptor subunits in human white and gray matter: potential mechanism of increased vulnerability in the immature brain.

Authors:  Lauren L Jantzie; Delia M Talos; Michele C Jackson; Hyun-Kyung Park; Dionne A Graham; Mirna Lechpammer; Rebecca D Folkerth; Joseph J Volpe; Frances E Jensen
Journal:  Cereb Cortex       Date:  2013-09-17       Impact factor: 5.357

6.  Axon-glia synapses are highly vulnerable to white matter injury in the developing brain.

Authors:  Yan Shen; Xiao-Bo Liu; David E Pleasure; Wenbin Deng
Journal:  J Neurosci Res       Date:  2011-08-02       Impact factor: 4.164

7.  Acute oligodendrocyte loss with persistent white matter injury in a third trimester equivalent mouse model of fetal alcohol spectrum disorder.

Authors:  Jessie Newville; Carlos Fernando Valenzuela; Lu Li; Lauren L Jantzie; Lee Anna Cunningham
Journal:  Glia       Date:  2017-05-18       Impact factor: 7.452

8.  Glutamate receptor 1 phosphorylation at serine 831 and 845 modulates seizure susceptibility and hippocampal hyperexcitability after early life seizures.

Authors:  Sanjay N Rakhade; Erin F Fitzgerald; Peter M Klein; Chengwen Zhou; Hongyu Sun; Richard L Huganir; Richard L Hunganir; Frances E Jensen
Journal:  J Neurosci       Date:  2012-12-05       Impact factor: 6.167

9.  Neurogenesis and neuronal commitment following ischemia in a new mouse model for neonatal stroke.

Authors:  S D Kadam; J D Mulholland; J W McDonald; A M Comi
Journal:  Brain Res       Date:  2008-03-04       Impact factor: 3.252

10.  Neonatal cerebral hypoxia-ischemia impairs plasticity in rat visual cortex.

Authors:  Samuel Failor; Vien Nguyen; Daniel P Darcy; Jianhua Cang; Michael F Wendland; Michael P Stryker; Patrick S McQuillen
Journal:  J Neurosci       Date:  2010-01-06       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.